Cadinha & Co. LLC Has $33.90 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cadinha & Co. LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 64,943 shares of the medical equipment provider’s stock after buying an additional 6,800 shares during the period. Intuitive Surgical makes up 5.6% of Cadinha & Co. LLC’s portfolio, making the stock its 3rd biggest position. Cadinha & Co. LLC’s holdings in Intuitive Surgical were worth $33,898,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Massachusetts Financial Services Co. MA acquired a new stake in Intuitive Surgical during the 3rd quarter worth $558,807,000. International Assets Investment Management LLC increased its holdings in shares of Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after acquiring an additional 1,088,415 shares in the last quarter. FMR LLC raised its position in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB lifted its holdings in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares in the last quarter. Finally, State Street Corp grew its position in shares of Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of ISRG opened at $592.64 on Friday. The company’s 50-day moving average is $540.66 and its 200-day moving average is $498.77. The firm has a market capitalization of $211.09 billion, a PE ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have commented on ISRG shares. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Citigroup boosted their price objective on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $554.17.

Insider Activity

In related news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at approximately $3,638,990. This represents a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.